2021 NASH TAG Conference | March 11-13, 2021 | Attended by Gregory T. Everson, MD and Brad Everson, CBDO
AASLD: The Liver Meeting Digital Experience | November 13-16, 2020 | Conference Website
- Poster: The HepQuant SHUNT Test of Global Liver Function and Physiology Identifies the Patients with Advanced Fibrosis or Compensated Cirrhosis Who are At-Risk for Hepatocellular Carcinoma
- Poster: Diagnostic Performance of The HepQuant Shunt Test in Prediction of Large Esophageal Varices in Well-Compensated Fibrosis or Cirrhosis Due to Chronic Hep C
Oral Presentation by Baylor – AASLD: The Liver Meeting Digital Experience | November 13-16, 2020
- Presentation: “Dual Cholate Test and Prediction of Decompensation, Liver Transplantation, Death and Hospitalization in Cirrhosis: A Prospective Study.